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Abstract: Vernonia fastigiata is a multi-purpose nutraceutical plant with interesting biological
properties. However, very little is known about its phytochemical composition and, thus the
need for its phytochemical characterization. In the current study, an environmentally friendly
method, pressurized hot water extraction (PHWE), was used to extract metabolites from the leaves
of V. fastigiata at various temperatures (50 ◦C, 100 ◦C, 150 ◦C and 200 ◦C). Ultra-high performance
liquid chromatography-quadrupole time of flight mass spectrometry (UHPLC-qTOF-MS) analysis
in combination with chemometric methods, particularly principal component analysis (PCA) and
liquid/gas chromatography mass spectrometry (XCMS) cloud plots, were used to descriptively
visualize the data and identify significant metabolites extracted at various temperatures. A total of
25 different metabolites, including hydroxycinnamic acid derivatives, clovamide, deoxy-clovamide
and flavonoids, were noted for the first time in this plant. Overall, an increase in extraction
temperature resulted in an increase in metabolite extraction during PHWE. This study is the
first scientific report on the phytochemical composition of V. fastigiata, providing insight into the
components of the chemo-diversity of this important plant.
Keywords: Vernonia fastigiata; PHWE; chemometrics; clovamide; cloud plot; deoxyclovamide;
flavonoids; PCA; XCMS
1. Introduction
The genus Vernonia, belonging to the family Asteraceae, is made up of more than a
thousand species distributed in the New and Old Worlds [1]. Many of these species, particularly
Vernonia amygdalina, have been noted to be rich in nutrients [2] and possessing biological activities
such as anti-bacterial [3], anti-viral [4] and anti-malarial/anti-plasmodial properties [5]. The bioactive
properties of this species have been attributed to the presence of sesquiterpene lactones (SL) [3] and
flavonoids [6]. Vernonia fastigiata Oliv. & Hiern is a perennial herb 0.1 to 1 m tall and is a basionym for
Parapolydora fastigiata [7]. This plant has been said to possess anti-plasmodial [8] and anti-bacterial
properties [9]. However, little is known about the phytochemical composition.
Traditionally, phytochemical studies often involve organic solvent-based extractions, however,
these are quite toxic and have called for the development of safer alternative extraction methods [10].
Pressurized hot water extraction (PHWE) is a green extraction method that uses pressurized water at
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elevated temperatures to extract different classes of plant compounds. At these elevated temperatures
and pressures, the polarity of water decreases close to that of common alcohols (e.g., methanol and
ethanol). Thus, plant compounds of varying polarities can be dissolved and extracted by water under
these conditions [10,11]. The ability of PHWE to extract different bioactive plant compounds has been
shown elsewhere [12,13]. PHWE is a technique capable of extracting a plethora of plant metabolites
and analysis is often accomplished by liquid chromatography hyphenated to mass spectrometry
(LC-MS). To study the resulting high dimensional LC-MS data, visualization statistical models must be
applied [14].
The current study was undertaken primarily to study the phytochemistry of V. fastigiata with
the aid of the green extraction technology PHWE along with multivariate analysis methods. Here,
principal component analysis (PCA) score plots were used to reduce the dimensionality of the data
sets and to visualize the chemo-diversity of extracts achieved at various temperatures. Moreover, the
interactive liquid/gas chromatography mass spectrometry (XCMS) cloud plots [15] provided statistical
descriptions of qualitative and quantitative (temperature-related) changes in extracted metabolites.
2. Results and Discussion
Several Vernonia species are used for their nutritional value and as folklore remedies for the
treatment of various human ailments, various compounds responsible for these nutraceutical and
biological activities have been isolated and studied [2]. Although V. fastigiata has been found to possess
anti-malarial [8] and anti-bacterial activities [9], the phytochemical composition of this plant has not
been studied. Thus, in this study, we explored the phytochemical compounds of V. fastigiata using
the green extraction technique PHWE, operating at different temperatures (50 ◦C, 100 ◦C, 150 ◦C and
200 ◦C).
Traditional medicine practitioners often boil or mix medicinal plants with warm water to
achieve the extraction of different classes of bioactive compounds. Thus, PHWE is a feasible
“green” extraction technique that mimics the extraction methods used by most traditional healers.
This method of extraction is non-toxic and takes advantage of the changes in the physicochemical
properties of water [10]. At a high temperature and constant pressure, the dielectric constant
of water decreases and, consequently, at different temperatures, water is capable of extracting
compounds with a wide polarity range, from polar to mid-polar to non-polar (Supplementary Materials,
Figure S1). Furthermore, this is also shown in the ultra-high performance liquid chromatography-mass
spectrometry (UHPLC-MS) chromatograms (Figure 1), where the greatest variation in peak intensity
was seen between temperatures of 50 ◦C and 200 ◦C. From these results, the peak intensity of mid-polar
and non-polar metabolites is low within the samples extracted at 50 ◦C in comparison to that extracted
at 200 ◦C (Figure 1). At room temperature or low temperatures, water is highly polar (i.e., has a high
dielectric constant) and viscous; however, an increase in temperature results in a decrease in these
properties accompanied by an increase in the diffusive properties of water through the cell matrix [10].
Thus, at high temperature, water exhibits heightened extractive abilities of compounds with varying
polarities [11]. However, MS-based methods are known to result in very high dimensional data which,
sometimes, is difficult to handle with traditional statistics and, as such, multivariate data models are
preferred to unearth such subtle differences [16].
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Figure 1. Ultra-high performance liquid chromatography (UHPLC) mass chromatograms, obtained 
using electrospray ionization (ESI) in negative mode, representing pressurized hot water extraction 
(PHWE) of Vernonia fastigiata metabolites at: (A) 50 °C; and (B) 200 °C. 
The effect of temperature on the extraction of the bioactive compounds was consequently 
investigated using PCA as a multivariate statistical tool (Figure 2). This unsupervised chemometric 
model extracts meaningful information from high dimensional metabolic datasets and highlights 
similarities or differences within and between sample groupings [17]. The score plot depicted sample 
groupings (Figure 2), where all the samples representing extracts achieved at 50 °C and 100 °C, 
respectively, are separately clustered together, and also separated from the other samples (thus 
extracts achieved with 150 °C and 200 °C). Interestingly, samples extracted at 150 °C and 200 °C can 
be seen to form a very distinctive cluster, together and away from samples achieved at 50 and 100 °C. 
Moreover, the tight grouping of samples extracted at 150 °C and 200 °C is an indication that these 
samples share common metabolite profiles (Figure 2). In addition, the PCA score plot shows 
differences between groups along the x-axis and differences within groups along the y-axis with 72% 
of the total variation accounted for, showing the robustness of this model. 
 
Figure 2. Principal component analysis (PCA) of the ultra-high performance liquid chromatography-
mass spectrometry (UHPLC-MS) chromatograms from negative ionization data. The 2D score plot, 
explaining 72% of the total variation, shows differences in the clustering patterns of V. fastigiata 
samples extracted at different temperatures using PHWE. 
Figure 1. Ultra-high performance liquid chromatography (UHPLC) mass chromatograms, obtained
using electrospray ionization (ESI) in negative mode, representing pressurized hot water extraction
(PHWE) of Vernonia fastigiata metabolites at: (A) 50 ◦C; and (B) 200 ◦C.
The effect of temperature on the extraction of the bioactive compounds was consequently
investigated using PCA as a multivariate statistical tool (Figure 2). This unsupervised chemometric
model extracts meaningful information from high dimensional metabolic datasets and highlights
similarities or differences within and between sample groupings [17]. The score plot depicted sample
groupings (Figure 2), where all the samples representing extracts achieved at 50 ◦C and 100 ◦C,
respectively, are separately clustered together, and also separated from the other samples (thus extracts
achieved with 150 ◦C and 200 ◦C). Interestingly, samples extracted at 150 ◦C and 200 ◦C can be seen to
form a very distinctive cluster, together and away from samples achieved at 50 and 100 ◦C. Moreover,
the tight grouping of samples extracted at 150 ◦C and 200 ◦C is an indication that these samples share
common metabolite profiles (Figure 2). In addition, the PCA score plot shows differences between
groups along the x-axis and differences within groups along the y-axis with 72% of the total variation
accounted for, showing the robustness of this model.
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From the PCA loadings plot (Figure 3), mass ions associated with the distribution patterns
observed on the PCA score plot between groupings were further investigated. From these
investigations, different metabolites were tentatively identified (Table 1, Figure 4) using metabolite
information databases such as Dictionary of Natural Products (DNP) [18] and KNApSAck [19]. A total
of 25 different metabolites made up of hydroxycinnamic acid (HCA) derivatives and quercetin-derived
flavonoids were tentatively identified (Table 1, Figure 4).
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Figure 3. PCA loadings plot showing the selection of V. fastigiata metabolites associated with different 
extraction temperature conditions. The mass ions on the upper-left quadrant (light-blue ring) are 
associated with PHW extraction at 50 °C; ions on the lower-right quadrant (green ring) are associated 
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are associated with extraction at 150 °C and 200 °C. 
Table 1. Table listing annotated metabolites extracted from Vernonia fastigiata by pressurized hot 
water extraction (PHWE) 
Molecule 
Number 
Rt 
(min) Compound Name 
Negative 
Ionization 
(m/z) 
Negative Ionization MS/MS Reference 
1 2.87 3-O-caffeoylquinic acid * 353.0860 353→191 #, 179,135 [20] 
2 5.56 5-O-caffeoylquinic acid * 353.0887 353→191 # [20,21] 
3 6.00 4-O-caffeoylquinic acid * 353.0825 353→191, 179, 173 # [20,22] 
4 7.99 cis-5-O-caffeoylquinic acid 353.0806 353→191 # [20,23] 
5 8.14 cis-N-caffeoyl-L-DOPA (cis-clovamide) 358.0879 358→222, 178 #, 161 [24,25] 
6 8.64 3-O-p-coumaroylquinic acid 337.0873 337→191 #, 163 [20,22] 
7 10.13 3-O-feruloylquinic acid 367.1044 367→191 #, 193 [20] 
8 10.74 trans-N-caffeoyl-L-DOPA (clovamide) 358.0871 358→222, 178 #, 161 [24,25] 
9 10.82 5-O-p-coumaroylquinic acid 337.0901 337→191 # [20,22] 
10 12.23 quercetin-3-O-hexoside-O-pentoside 595.1245 595→301, 300 #, 271, 255, 243 [26] 
11 12.41 quercetin-3-O-pentoside-O-hexoside 595.1288 595→301, 300 #, 271, 255 [27] 
12 12.64 quercetin-3-O-hexoside-O-pentoside-O-malonyl 681.1300 681→637, 595, 301, 300 #, 271, 255 MS/MS spectra
13 12.81 N-caffeoyl-L-tyrosine (deoxyclovamide) 342.0944 342→342 #, 206 MS/MS spectra
14 13.24 quercetin-3-O-hexoside-O-pentoside-O-acetyl 637.1335 637→595, 301, 300 #, 271, 255, 243 MS/MS spectra
15 13.42 quercetin-3-O-galactoside 463.0857 # 463→301, 300, 271, 255, 243 [26,28,29] 
16 13.60 5-O-feruloylquinic acid 367.1008 # 367→191 [20] 
17 13.71 quercetin-3-O-glucoside (isoquercetin) * 463.0835 463→301, 300 #, 271, 255, 243 [26,28,29] 
18 14.04 quercetin-3-O-galactoside-O-acetyl 505.0955 505→463, 301, 300 #, 271, 255, 243 MS/MS spectra
19 14.13 3,4-di-O-caffeoylquinic acid isomer 515.1113 515→353, 335, 191, 179, 173 # [20,22] 
20 14.28 quercetin-3-O-glucoside-O-acetyl 505.0970 # 505→463, 301, 300, 271, 255 MS/MS spectra
21 14.42 3,5-di-O-caffeoylquinic acid isomer * 515.1123 515→353, 191 #, 179 [20,22] 
22 14.58 3,5-di-O-caffeoylquinic acid isomer 515.1082 515→353, 191 #, 179 [20,22] 
23 15.00 quercetin-3-O-rhamnoside (quercetrin) 447.0850 447→301, 300 #, 271, 255, 243 [28,29] 
24 15.24 4,5-di-O-caffeoylquinic acid * 515.1099 515→353, 191, 179, 173 # [20,22] 
25 16.49 3,4-di-O-caffeoylquinic acid isomer * 515.1128 515→353, 335, 191, 179, 173 # [20,22] 
# base peak; * Metabolites with identical Rt and MS/MS spectra to available standards. 
Figure 3. PCA loadings plot showing the selection of V. fastigiata metabolites associated with different
extraction temperature conditions. T e mass ions on the upper-left quadrant (light-blue ring) are
associated with PHW xtraction at 50 ◦C; ions on the lower-right quadrant (green ring) are associated
with extraction at 100 ◦C, nd ions on the right (upp r and low; red nd dark-blue i ) quadrants are
associated with extraction t 150 ◦C a d 200 ◦C.
Table 1. Table listing annotated metabolites extracted from Vernonia fastigiata by pressurized hot water
extraction (PHWE).
Molecule
Number
Rt
(min) Compound Name
Negative
Ionization (m/z) Negative Ionization MS/MS Reference
1 2.87 3-O-caffeoylquinic acid * 353.0860 353→191 #, 179,135 [20]
2 5.56 5-O-caffeoylquinic acid * 353.0887 353→191 # [20,21]
3 6.00 4-O-caffeoylquinic acid * 353.0825 353→191, 179, 17 # [20,22]
4 7.99 cis-5-O-caffeoylquinic acid 353.0806 353→191 # [20,23]
5 8.14 cis-N-caffeoyl-L-DOPA (cis-clovamide) 358.0879 358→222, 178 #, 161 [24,25]
6 8.64 3-O-p-coumaroylquinic acid 337.0873 337→191 #, 163 [20,22]
7 10.13 3-O-feruloylquinic acid 367.1044 367→191 #, 193 [20]
8 10.74 tr ns-N-caffeoyl-L-DOPA (clovamide) 358.0871 358→ 2, 178 , 1 [24, 5]
9 10.82 5-O-p-coumaroylquinic acid 337.0901 337→191 # [20,22]
10 12.23 quercetin-3-O-hexoside-O-pentoside 595.1245 595→301, 300 #, 271, 255, 243 [26]
11 12.41 quercetin-3-O-pentoside-O-hexoside 595.1288 595→301, 300 #, 271, 255 [27]
12 12.64 quercetin-3-O-hexoside-O-pentoside-O-malonyl 681.1300 681→637, 595, 301, 300 #, 271, 255 MS/MS spectra
13 12.81 N-caffeoyl-L-tyrosine (deoxyclovamide) 342.0944 342→342 #, 206 MS/MS spectra
14 13.24 q tin-3-O-hexoside-O pentoside-O-acetyl 637.1335 637 595, 301, 300 #, 271, 255, 243 MS/MS spectra
15 13.42 quercetin-3-O-galactoside 463.0857 # 463 301, 300, 271, 255, 243 [26,28,29]
16 13.60 5-O-feruloylquinic acid 367.1008 # 367→191 [20]
17 13.71 quercetin-3-O-glucoside (isoquercetin) * 463.0835 463→301, 300 #, 271, 255, 243 [26,28,29]
18 14.04 quercetin-3-O-galactoside-O-acetyl 505.0955 505→463, 301, 300 #, 271, 255, 243 MS/MS spectra
19 14.13 3,4-di-O-caffeoylquinic acid isomer 515.1113 515→353, 335, 191, 179, 173 # [20,22]
20 14.28 qu i -3-O-glucoside-O-acetyl 505.09 0 # 505→463, 3 1, 300, 71 55 MS/MS spectra
21 14.42 3,5-di-O-caffeoylqui ic acid isomer * 515.1123 515→353, #, 179 [20,22]
22 14.58 3,5-di-O-caffeoylquinic acid isomer 515.1082 515→353, 191 #, 179 [20,22]
23 15.00 quercetin-3-O-rhamnoside (quercetrin) 447.0850 447→301, 300 #, 271, 255, 243 [28,29]
24 15.24 4,5-di-O-caffeoylquinic acid * 515.1099 515→353, 191, 179, 173 # [20,22]
25 16.49 3,4-di-O-caffeoylquinic acid isomer * 515.1128 515→353, 335, 191, 179, 173 # [20,22]
# base peak; * Metabolites with identical Rt and MS/MS spectra to available standards.
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Figure 4. Chemical structures of annotated hydroxycinnamic acid (HCA) derivatives and quercetin-
derived flavonoids in V. fastigiata. 
To further complement the descriptive view provided by the PCA score plot (Figure 2) and to 
visualize the metabolite variation between samples extracted at different temperatures, XCMS 
online-based cloud plots [15] were constructed (Figure 5). The cloud plots show data characteristics 
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between 50 °C and 100 °C (Figure 5A), 608 features were detected between 50 °C and 150 °C (Figure 
5B) and 653 features were detected between 50 °C and 200 °C (Figure 5C), an indication that 
temperature did indeed affect the number of metabolites extracted. On the cloud plot, features with 
increased intensity due to the increase in extraction temperature (100 °C, 150 °C and 200 °C) are 
shown on top of the plot (in green) and features with low intensity due to low extraction temperature 
(i.e., 50 °C) are shown at the bottom of the plot (in red) (Figure 5). As stated above, the plots show 
that the number of features (phytochemicals) that were altered/extracted are associated with an 
increase in temperature. In addition, these plots show an increase in temperature results in an 
increase in the extraction of mid-polar (red box) and non-polar phytochemicals. This observation 
reiterates the role of the extraction temperature for efficient and selective extraction of metabolites 
during PHWE. 
The results show a further increase in temperature, however, leads to a point of saturation where the 
number of extracted metabolites do not increase beyond a certain extraction temperature (Figure 5F), i.e., 
between 150 °C and 200 °C in this case. Here, only 22 features were altered between 150 and 200 °C 
(Figure 5F), compared to the 653 features that were altered between 50 °C and 200 °C (Figure 5C). 
This cloud plot (Figure 5F) explains the clustering of plant samples extracted at these temperatures 
(150 °C and 200 °C) previously observed on the PCA score plot (Figure 2), where very little differences 
between these samples were observed. Furthermore, at such elevated temperatures (150 °C and 200 
°C) differences in the classes of extracted metabolites may be too minor to show significant differences 
or thermally labile metabolites may have undergone degradation [10]. For instance, previously it was 
reported that elevated temperatures resulted in the formation of carcinogenic compounds such as 
hydroxymethylfurfural [30]. These possibilities suggest that some metabolites may require optimal 
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and 653 featur s were detecte b tween 50 ◦C and 200 ◦C (Figure 5C), an indication that temperature
did indeed affect th number of metabolites extracted. On the cloud plot, features with increased
i tensity due to the increase in extraction temperature (100 ◦C, 150 ◦C and 200 ◦C) are shown on top
of the plot (in green) and features with low intensity due to low extraction temperature (i.e., 50 ◦C)
ar shown t the bottom of the plot (in r d) (Figur 5). As stated above, the plots show that the
number of features (phytochemicals) that were altered/ xtract are associated with an increase i
temperature. In addition, these plots show an increase in temper ture results in an increase i the
extraction of mid-polar (red box) and non-polar phytochemicals. This observation reiterates the role of
the extraction temperature for efficient and selective extraction of metabolites during PHWE.
The results show a further increase in temperature, however, leads to a point of saturation
where the n mber of extracted metabolites do not increase beyon a certain extr ction temperature
(Figure 5F), i.e., between 150 ◦C and 200 ◦C in this case. Here, only 22 features were altered between
150 and 20 ◦ (Figure 5F), comp red to the 653 features that were altered between 50 ◦C and
200 ◦C (Figure 5C). This cloud plot (Figure 5F) explains the clustering of plant samples extracted
at these temperatures (150 ◦C and 200 ◦C) previously observed on the PCA score plot (Figure 2),
where very little differences between these samples were observed. Furthermore, at such elevated
temperatures (150 ◦C and 200 ◦C) differences in the classes of extracte metabolites may be too minor
to show significant differences or thermally la ile metabolites may have undergone degra ation [10].
For instance, previously it was reported that elevated temperatures resulted in the f rmation of
carcinogenic compounds such as hydroxymethylfurfural [30]. These possibilities suggest that some
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metabolites may require optimal temperature conditions for extraction. The best extraction temperature
condition(s) for each annotated metabolite (Table 1) were graphically described by box-and-whiskers
plots (boxplot) (Figure 6), where, following ANOVA analysis, it was possible to indicate temperature
conditions that resulted in significant differences (p value ≤ 0.01) in yield patterns for each metabolite.
However, the levels of some pharmacologically relevant metabolites (e.g., 3, 11, 13, 17–19, 22 and
25) were not statistically significant (p value ≤ 0.01) across data sets and were thus not graphically
presented by boxplots. From the boxplots (Figure 6), the general trend observed is that an increase in
temperature results in an increase in the intensity of each molecule/metabolite. However, sensitivity
to temperature of some molecules was also observed, where at temperatures below 100 ◦C, molecules
5 and 8 were not extracted at all. However, the intensities of these molecules show an increase with an
increase in temperature, for instance at 150 ◦C and 200 ◦C. Some molecules, however, were negatively
affected by temperatures beyond 100 ◦C and show a decrease in the intensity, possibly due to thermal
decomposition (for instance, molecule/metabolite 9) (Figure 6).
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Figure 5. Liquid/gas chromatography mass spectrometry (XCMS) cloud plot of UHPLC-MS data: (A) 
ion comparisons between 50 °C and 100 °C; (B) ion comparisons between 50 °C and 150 °C; (C) ion 
comparisons between 50 °C and 200 °C; (D) ion comparisons between 100 °C and 150 °C; (E) ion 
comparisons between 100 and 200 °C; and (F) ion comparisons between 150 °C and 200 °C. The ions that 
are enhanced due to an increase in temperature (100 °C, 150 °C and 200 °C) are shown in the top plots 
(in green) and the ions that were extracted at a low temperature are shown in the bottom plot (in red). 
Figure 5. Liquid/gas chromatography mass spectrometry (XCMS) cloud plot of UHPLC-MS data:
(A) ion comparisons between 50 ◦C and 100 ◦C; (B) ion comparisons between 50 ◦C and 150 ◦C; (C) ion
compari t een 50 ◦C and 200 ◦C; (D) ion comparisons between 100 ◦C and 150 ◦C; (E) ion
comparisons between 100 and 200 ◦C; and (F) ion co parisons between 150 ◦C and 200 ◦C. The ions
that are enhanced due to an increase in temperature (100 ◦C, 150 ◦C and 200 ◦C) are shown in the top
plots (in green) and the ions that were extracted at a low temperature are shown in the bottom plot
(in red).
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however, due to the lack of standards for the rest of the metabolites, MS fragmentation patterns and 
chromatographic elution order for flavonoids [21,26–28] and chlorogenic acids [20,22,23] were 
compared with literature reports for annotation. Table 1 shows that the leaves of V. fastigiata are rich 
in chlorogenic acids (CGAs) as well as in glycosylated quercetin derivatives (flavonols). Interestingly, 
Figure 6. Box-and-whiskers plots showing the optimal temperature conditions for 17 different
metabolites indicated in Table 1. All significant differences are based on ANOVA with p ≤ 0.01.
Metabolites are made up of hydroxycinnamate derivatives (1, 2, 4–9, 16, 21 and 24) and
quercetin-derived flavonoids (10, 12, 14, 15, 20 and 23) extracted from V. fastigiata during
PHW extraction.
In Table 1, differe t metabolites were tentatively identified using DNP [18] and KNApSAcK [19]
metabolite information datab ses. Authentic standards w re also used to identify some metabolites,
however, due to the lack f standards f r the rest of the metabolites, MS fr gmentation patterns
and ch omatographic elution order for flavonoids [21,26–28] and chlorogenic acids [20,22,23] were
compa ed with literature reports for nnotation. T ble 1 shows that the leaves of V. fastigiata are r ch in
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chlorogenic acids (CGAs) as well as in glycosylated quercetin derivatives (flavonols). Interestingly,
other biologically active HCA derivatives, namely clovamide (5 and 8) [24,31] and deoxyclovamide
(13) [31], were also found.
2.1. Identification of Various HCA Derivatives in V. fastigiata
HCA derivatives found in V. fastigiata include 1–9, 13, 16, 19, 21–22 and 24–25 (Table 1 and
Figure 4). For annotated chlorogenic acids (1–4, 6–7, 9, 16, 19, 21–22 and 24–25), six types of
fragmentation rules were noted: neutral ions attributed to the loss of a quinic acid (−174 Da), caffeic
acid (−162 Da), p-coumaric acid (−146 Da) and ferulic acid moieties (−176 Da), as well as carbon
dioxide (−44 Da) and H2O (−18 Da).
Molecules 1–4 with a precursor ion, [M − H]−, at m/z 353 were identified as mono-caffeoylquinic
acids. Further inspection of the UHPLC chromatogram and mass spectra of these metabolites revealed
1 at Rt 2.87 min to contain fragment ions at m/z 191, 179 and 135. These ions resulted from the loss
of a caffeic acid moiety, the loss of a quinic acid moiety and the decarboxylation of the caffeic acid
moiety, respectively. The relative abundance of the ion at m/z 191 base peak (bp) relative to the ion at
m/z 179 is a typical characteristic of 3-caffeoylquinic acid (3-CQA) [20]. For 2 at Rt 5.56 min, a single
fragment ion at m/z 191 was obtained due to the sequential loss of a caffeic acid moiety and 2 was
characterized as 5-CQA [20,21]. Molecule 3 at Rt 6.00 min showed fragment ions at m/z 191, 179 and
173 resulting from the loss of a caffeic acid moiety, loss of a quinic acid moiety and the presence of a
dehydrated quinic acid moiety, respectively. The presence of the ion at m/z 173 is diagnostic of a HCA
derivative esterified at position 4 on the quinic acid [22] thus 3 was annotated as 4-CQA. Molecule 4
at Rt 7.99 min showed the same fragmentation pattern as 2, thus this molecule was annotated as an
isomer of 5-CQA. Based on the elution order suggested by Clifford et al. on a reverse-phase column,
4 relative to 2 was annotated as cis-5-CQA [23]. Geometrical isomers of HCA derivatives have been
known to show the same MS fragmentation patterns [23,32] and the ability to distinguish cis isomers
from their trans counterparts has proven to be a challenge.
However, progress has been made where cis isomers of di-caffeoylquinic acids (diCQA) were
shown to preferentially bind to alkali metals, whereas trans-isomers did not [32]. In addition, positional
isomers of mono-CQAs in this study were identified with the use of authentic standards.
Molecule 5 and 8, at Rt 8.14 min and 10.74 min, respectively, showed a precursor ion at m/z 358
[M−H]− (Supplementary Materials, Figure S2). For both molecules (5 and 8), the fragment ions observed
were 222, 178 and 161 (Supplementary Materials, Figure S3) due to the loss of the vinyl-catecholic
fragment [M − H − 136]−, the loss of a deaminated L-DOPA (3,4-dihydroxyphenylalanine) fragment
[M − H − 180]− [24] and the ion at m/z 161 possibly representing a dehydrated-caffeoyl amide moiety.
Thus, 5 and 8 were characterized as clovamide (N-caffeoyl-L-DOPA (3,4-dihydroxyphenylalanine))
isomers. From a study by Locatelli et al., where the trans and cis isomers of clovamide were noted, the
earlier eluting isomer (thus 5) was identified as the cis isomer and the later eluting isomer (thus 8) was
identified as the trans isomer [25]. Molecules 6 and 9 showed a precursor ion of m/z 337 [M − H]− at
Rt 8.64 and 10.82 min, respectively. Molecule 6 showed fragment ions at m/z 191 and 163, representing
the loss of both p-coumaroyl and quinic acid moieties, respectively. The abundance of the ion at m/z
191 relative to the ion at m/z 163 characterized 6 as 3-p-coumaroylquinic acid (3-pCQA). Molecule 9
showed a single fragment ion at m/z 191 resulting from the loss of a p-coumaroyl moiety, thus 9 was
annotated as 5-pCQA [22]. Molecules 7 and 16 at Rt 10.13 min and 13.60 min, respectively, showed a
precursor ion at m/z 367 [M − H]−. Molecules 7 and 16 showed fragment ions at m/z 191 and 193
representing the loss of a feruloyl and quinic acid moieties, respectively. The abundance of the ion at
m/z 191 led to the annotation of 7 as 3-feruloylquinic acid (3-FQA) [20]. The presence and abundance
of fragment ion at m/z 191 supported the annotation of 16 as 5-FQA [20].
Molecule 13 at Rt 12.81 min showed a precursor ion at m/z 342 and a fragment ion at
m/z 206 (Supplementary Materials, Figure S4) due to the loss of the vinyl-catecholic fragment
[M − H − 136]−. The molecular formula (C18H17NO6) of this compound led to the tentative
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annotation as deoxyclovamide (N-caffeoyl-L-tyrosine). Molecules 19, 21, 22, 24 and 25 showed
precursor ions at m/z 515 [M − H]−, suggesting di-caffeoylquinic acid (diCQA) isomers. Molecules
19, 24 and 25 showed fragment ions at m/z 173, which, as stated above, is indicative of acylation
at position 4 on the quinic acid unit. Molecules 19 and 25 at Rt 14.13 and 16.49 min, respectively,
showed similar fragmentation patterns. The observed fragment ions were at m/z 335, 191, 179 and 173,
thus 19 and 25 were annotated as 3,4-diCQA isomers. As the plant biosynthetic pathway produces
molecules in the trans geometry and exposure of the plant to the suns UV-rays causes photochemical
isomerization to the cis geometry [23], the low peak intensity of 19 relative to 25 suggests that the
former is a cis isomer of the latter.
Molecule 24 at Rt 15.24 min was annotated as 4,5-diCQA due to the absence of the fragment ion
at m/z 335, the presence of the fragment ions at m/z 179, 191 and abundance of the ion at m/z 173.
Molecules 21 and 22 at Rt 14.42 and 14.58 min, respectively, were annotated as 3,5-diCQA isomers
due to the presence of ions at m/z 191 and 179, the abundance of the fragment ion at m/z 191 and the
absence of the ion at m/z 173. Due to the high peak intensity of 21 relative to 22, it is suggested that
the latter is the cis isomer of the former.
Biological Relevance of Identified HCA Derivatives
Plant secondary metabolites such as CGAs are HCA derivatives and are formed from the
transesterification reaction between a quinic acid unit and HCAs such caffeic acid, ferulic acid and
p-coumaric acid [22,23]. The trans-HCA can be esterified to one or more of the four hydroxyl groups at
positions 1, 3, 4 and 5 on the quinic acid unit, thus giving rise to various positional isomers. Therefore,
from Table 1, V. fastigiata contains a number of both mono- and di-acylated CGAs (1–4, 6–7, 9, 16, 19,
21–22, and 24–25). These metabolites and their derivatives have also been isolated and identified in
other Vernonia species [1,2]. Moreover, these compounds have been associated with various health
benefits and are acclaimed for their anti-oxidant activity [33]. The caffeic acid-derived CGAs show
the most potent anti-oxidant activity, which is attributed to the catechol group at positions 3 and
4 on the HCA [21]. In some plants, of the four positional isomers (1, 3, 4 and 5-acylated isomers),
5-caffeoylquinic acid (5-CQA) is considered a major anti-oxidant [34]. In addition, other positional
isomers have been noted to possess the ability to prevent liver disease (for instance, 3-CQA) [35] and
possess anti-inflammatory activity (for instance, 4-CQA) [36]. The presence of diCQAs were also
annotated in V. fastigiata, where in another study 3,4-diCQA and 3,5-diCQA were noted to possess
anti-microbial and anti-viral activities [37] with 3,5-diCQA showing anti-human immunodeficiency
virus (HIV) type 1 DNA integrase activity [38]. Furthermore, 4,5-diCQA has been noted to exhibit
anti-inflammatory effects [39]. In addition to possessing positional isomers of CGAs (i.e., 1–3),
V. fastigiata also contains geometrical isomers of some of these phenolic compounds, for example
5-CQA (2) and cis-5-CQA (4). This large pool of (poly)phenolics is described by the “better safe than
sorry” phenomenon [21]. Whereby, for survival and protection, the plant produces multiple structurally
similar metabolites that contribute to the state of readiness within the plant. As sessile organisms,
plants are constantly exposed to various stressors resulting in oxidative stress, thus to mitigate the
effects thereof plants use the readily available phenolic compounds of similar structures [21]. Therefore,
the similarities and minor differences in structural configuration of the phenolic compounds can be
thought to add to the diversity of the plant metabolome.
Furthermore, two other HCA-derived metabolites; clovamide (5 and 8) (N-caffeoyl-L-DOPA) and
deoxyclovamide (13) (N-caffeoyl-L-tyrosine), were also extracted. Clovamide is a bioactive compound
and reported to possess radical scavenging properties [24]. To the best of our knowledge this is the first
identification of this metabolite in Old World Vernonia species such as V. fastigiata [1,7]. Clovamide was,
however, identified by Martucci et al. in New World Vernonia species found in the genera Chrysolaena
(Vernonia herbacea and Vernonia platensis) [1]. These two species were the only two of the ten Vernonia
species studied that accumulated this metabolite, and thus clovamide was used as a chemo-marker
for the taxonomic classification of the species found in the Chrysolaena genera. Clovamide has been
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noted as being abundant in cacoa seeds from which cocoa beverages and chocolates are produced [40].
This metabolite is structurally similar to rosmarinic acid (also a caffeic acid derivative), a known
potent anti-oxidant, and the two have been shown to have comparative anti-oxidant properties [41].
In addition, clovamide exhibited the inhibition of lipid peroxidation [25] and in a separate study by
Fallarini et al., was found to have neuroprotective effects [42]. Deoxyclovamide as an anti-oxidant has
also been reported elsewhere, although showing less anti-oxidant activity than clovamide [31].
2.2. Identification of Various Glycosylated Quercetin Derivatives in V. fastigiata
V. fastigiata leaves contain a variety of glycosylated quercetin metabolites, where 10–12, 14–15,
17–18, 20 and 23 were identified as glycosylated quercetin derivatives due to the presence of the
fragment ion at m/z 301. Characterization was achieved by the loss of neutral ions attributed to hexose
(−162 Da), pentose (−132 Da), rhamnose (−146 Da), disaccharide of glucose and pentose (−294 Da),
malonyl pentose (−218 Da), malonyl (−86 Da) or acetyl moieties (−42 Da).
Molecules 10 and 11 with a [M – H]− ion at m/z 595 were characterized as quercetin-hexoside-
pentoside and quercetin-pentoside-hexoside, respectively [26,27]. For 10 at Rt 12.23 min, fragment
ions at m/z 463, 301 and 300 were obtained due to the sequential loss of a terminal pentose and
hexose moieties [26]. Molecule 11 at Rt 12.41 min showed fragment ions at m/z 433, 301 and 300, and
these resulted from the sequential loss of a terminal hexose and pentose moieties [27]. Due to the
abundance of the radical aglycone ion at m/z 300 relative to the aglycone ion at m/z 301, glycosylation
of quercetin was determined to be at position 3 for both molecules [29]. Thus, 10 was characterized as
quercetin-3-O-hexoside-O-pentoside and 11 as quercetin-3-O-pentoside-O-hexoside.
Molecule 12 at Rt 12.64 min showed a precursor ion at m/z 681 [M −H]− as well as fragment ions
at 595, 463, 301 and 300 resulting from the sequential loss of the malonyl, pentose and hexose moieties,
respectively. As such, due to the abundance of the radical aglycone at m/z 300, 12 was characterized
as quercetin-3-O-hexoside-O-pentoside-O-malonyl. The mass spectra of 14 at Rt 13.24 min displayed
a precursor ion at m/z 637 [M − H]− and three fragment ions with one at m/z 595 due to the
loss of a terminal acetyl moiety, one at m/z 463 due to the loss of a pentose moiety and one at
m/z 301 due to the subsequent loss of a hexose moiety. Molecule 14 was thus characterized as
quercetin-3-O-hexoside-O-pentoside-O-acetyl due to the observed abundance of the radical aglycone
ion at m/z 300. Molecule 15 and 17 showed a precursor ion at m/z 463 [M − H]− with Rt 13.42 and
13.71 min, respectively. Mass spectra of these two molecules showed fragment ions at m/z of 301 and
300, due to the loss of a terminal hexose moiety with m/z 162. The abundance of the radical aglycone
ion at m/z 300 indicated that the glycosylation of quercetin was at position 3. Thus 15 and 17 were
characterized as quercetin-3-O-hexoside isomers. However, considering the elution order of the two
molecules on a reverse-phase column, 15 was characterized as quercetin-3-O-galactoside and 17 as
quercetin-3-O-glucoside [26,28].
Molecules 18 and 20 at Rt 14.04 min and 14.28 min, respectively, showed a precursor ion at
m/z 505 [M − H]−. For both molecules (18 and 20), the fragment ions observed were 463, 301 and
300, and resulted from the loss of the terminal acetyl and hexose moieties. Thus 18 and 20 were
characterized as quercetin-3-O-hexoside-acetyl isomers, because of the relative abundance of the
radical aglycone ion at m/z 300. Considering the elution order, these metabolites were characterized
as quercetin-3-O-galactoside-acetyl (18) and quercetin-3-O-glucoside-acetyl (20). Molecule 23 was
characterized as quercetin-rhamnoside with a precursor ion at m/z 447 [M − H]− and Rt at 15.00 min,
due to the presence of the fragment ions at m/z 301 and 300, resulting from the loss of a rhamnose
moiety [28]. The abundance of the fragment ion at m/z 300 indicated glycosylation at position 3, thus
23 was characterized as quercetin-3-O-rhamnoside.
Biological Relevance of Identified Quercetin Glycosylated Derivatives
Flavonoids are a major class of secondary metabolites in plants, and these polyphenolic
compounds are ubiquitous and involved in providing plants with their rich colors [43]. Flavonoids
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also act as secondary protectants for plants against different stressors, such as microbial infections
or UV-B radiation [21,43]. However, the upsurge in the interest of flavonoids is due to the proposed
health benefits, particularly the anti-oxidant activity. Of the many flavonoid classes that exist, the
bioactivity of the flavonol quercetin is well documented and is considered to be one of the most potent
of flavonoid anti-oxidants, where the anti-oxidant activity is dependent on the hydroxyl substitution
pattern on the B-ring [43]. Similar to caffeoyl-containing phytochemicals, the 3′,4′-catechol unit found
on the B-ring makes quercetin a significant scavenger of reactive oxygen species (ROS) [21]. Another
mechanism of anti-oxidant action used by quercetin is the suppression of ROS formation by chelating
free metal ions that enhance the process. Here the catechol unit along with other specific positions
(3-OH, 4-oxo and 5-OH) on the different rings, enhances the metal-chelating and metal-stabilizing
properties [43].
The aglycone, quercetin, has lipophilic properties and glycosylation enhances the solubility thereof
in the plant, thus allowing easier transportation into various cellular compartments. Glycosylation
or any modification of the aglycone reduces the anti-oxidant activity of the metabolite, compared to
the unbound aglycone, as specific positions (3-OH or 4′-OH) involved in radical scavenging and/or
ion-suppression may be occupied by sugar moieties. However, glycosylation is significant for the
bioavailability of the aglycone in plasma [43], and following hydrolysis of the sugar moiety, the
aglycone is absorbed and found in the plasma where it can exhibit different biological activities.
Moreover, quercetin has growth inhibitory effects against several malignant tumor cell lines [43].
Lastly, in an interesting study by Ganesh et al., quercetin and related quercetin derivatives were found
to exhibit anti-plasmodial activity [44], which might explain the purported anti-plasmodial activity of
V. fastigiata reported by Clarkson et al. [8].
3. Materials and Methods
3.1. Materials
Authentic standards of caffeic acid-derived chlorogenic acids (3-caffeoylquinic acid;
4-caffeoylquinic acid; 5-caffeoylquinic acid; 1,3-di-caffeoylquinic acid; 1,5-di-caffeoylquinic acid;
3,4-di-caffeoylquinic acid; 3,5-di-caffeoylquinic acid and 4,5-di-caffeoylquinic acid) and flavonols
(quercetin-3-O-glycoside; quercetin-4-O-glycoside; quercetin-7-O-glycoside and rutin) were purchased
from Phytolab (Vestenbergsgreuth, Germany). Analytical-grade acetonitrile was obtained from Romil
(Cambridge, UK). Formic acid and diatomaceous earth were obtained from Sigma-Aldrich (St. Louis,
MO, USA).
3.2. Methods
3.2.1. Extraction
V. fastigiata leaves were collected from the Venda region of the Limpopo province (South
Africa). Herbarium specimens (with voucher number MN 027/2016) were prepared and stored
in the Department of Botany at the University of Venda. Sample preparation and extraction procedures
were conducted according to Khoza et al. [13]. Briefly, V. fastigiata leaves were air-dried and pulverized
using a mortar and pestle. These dried, ground leaves (3 g) were then mixed with diatomaceous earth
(1 g) and metabolites were extracted with pure water (pH 6.8) using a homemade PHWE system [12].
The instrument was set at the desired temperature levels (50 ◦C, 100 ◦C, 150 ◦C and 200 ◦C), at a
constant pressure of 1000 ± 100 psi (68.9 ± 6.89) and flow rate of 5 mL/min. Five samples (50 mL) per
temperature setting were collected. Two milliliters (2 mL) of the extracts were filtered through 0.22 µm
membrane syringe filters into glass vials and stored at 4 ◦C prior to ultra-high performance liquid
chromatography-quadrupole time of flight mass spectrometry (UHPLC-qTOF-MS) analysis.
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3.2.2. Chromatography and Mass Spectrometry Analyses
Extracts obtained from the PHWE method were analyzed by injecting 3 µL into a Synapt G1
UHPLC-high definition MS instrument (Waters Corporation, Manchester, UK) equipped with a Waters
Acquity HSS T3 C18 column (150 mm × 2.1 mm with particle size of 1.8 µm), analyzed at a flow rate
of 0.4 mL/min. Three technical replicates from five independent extracts per temperature point were
analyzed on the UHPLC-qTOF-MS, resulting in fifteen replicates per temperature point. The mobile
phase for the chromatographic analysis consisted of 0.1% formic acid in MilliQ water (solvent A) and
0.1% formic acid in acetonitrile (solvent B). The initial conditions were 2% B at 1 min, followed by
multiple gradients to 60% B at 24 min and a steep gradient to 95% B at 25 min, the conditions were
kept isocratic for 2 min and then dropped to the initial conditions in 1 min, followed by 2 min isocratic
wash at 2% B to re-equilibrate the column. The column temperature was maintained at 60 ◦C. This
30 min chromatographic elution was monitored by both photodiode array (PDA) and MS detectors.
The PDA detectors (Waters Corporation, Manchester, UK) scanning range was set from 200 nm to
500 nm, with 1.2 nm bandwidth resolution and a sampling rate of 20 points/s. For MS, data were
acquired in negative and positive modes using optimized settings presented elsewhere [13], with the
scan time set at 0.1 s. In addition, increasing collision energies (CE) (10 eV, 20 eV, and 40 eV) were
utilized to achieve useful MS fragmentation data, for identification purposes.
3.2.3. Data Processing and Multivariate Data Analysis (MVDA)
UHPLC-MS raw data (ESI-negative mode) were extracted and imported into MassLynxTM
XS software (SCN 704, Waters Corporation, Mildford, MA, USA) for data processing. Briefly, the
following parameters were chosen: chromatogram retention time (Rt) range of 5–23 min, mass range of
100–1000 Da, mass tolerance of 0.02 Da, and Rt window of 0.2 min. The data matrix from MarkerLynx
was then exported into SIMCA version 13.0 software (Umetrics, Umea, Sweden) for PCA analyses.
Before PCA modelling, the pre-processed X data were centered and Pareto-scaled to put all variables
on equal footing, minimize variable redundancy and adjust for measurement errors. Furthermore,
a nonlinear iterative partial least squares algorithm (in-built within SIMCA) was used to handle
the missing values, with a correction factor of 3.0 and a default threshold of 50%. A seven-fold
cross-validation (CV) method was applied as a tuning procedure in computing the PCA models.
To complement SIMCA-based chemometric analyses, the raw data were further analyzed using
cloud-based informatics software (XCMS Online) [15].
XCMS online software is an open-source web-based software developed to process and visualize
untargeted MS-based metabolomics data [14]. The enhanced online interface allowed two-group
(paired) comparisons between different temperature conditions (i.e., 50 ◦C vs. 100 ◦C and 50 ◦C vs.
150 ◦C etc.). In addition, multi-group comparisons between the four temperature conditions (50 ◦C,
100 ◦C, 150 ◦C and 200 ◦C) were also performed. These comparisons (paired and multi-group) were
monitored with the interactive visualization tool known as a cloud plot [14]. Following the uploading
of the raw data files (NetCDF), parameters for XCMS processing were as follows: matchedFilter for
feature detection (with 0.1 step size to use for profile generation and 30 full width at half maximum
matched filtration Gaussian model peak), and peak groups for Rt correction (with linear alignment,
1 extra peak allowed in Rt correction groups and only 1 number of missing samples allowed in Rt
correction groups). The chromatogram alignment parameters were: minifrac of 0.5 (minimum fraction
of samples necessary in at least one of the sample groups for it to be a valid group), bandwidth (bw) of
10 s (allowable Rt deviations) and m/z width of 0.25 (width of overlapping m/z slices to use for peak
density chromatograms and grouping peaks across samples). Each cloud plot showed a fold change
of >1.5 and p values < 0.01, where the size of each bubble is associated with the log fold change of
each feature [14]. The statistical significance of the fold change is represented by the color intensity of
the feature, where features with darker colors have a higher p value than brighter colored features.
The statistical significance of the fold change was calculated by a Welch t test with unequal variance for
paired groups and calculated by ANOVA for multi-group comparisons. In addition, features denoted
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with a black outline are the ones with database hits in METLIN [45] and those denoted with a white
outline are the ones with no METLIN-based hits.
The effect of temperature on extraction for each metabolite (feature) was visualized on
box-and-whiskers plots (boxplots). Thus, the XCMS online analyses of the UHPLC-MS data
were coupled with the MarkerLynx and SIMCA-based analyses to comprehensively study the role
temperature plays during metabolite extraction by PHWE.
3.2.4. Metabolite Annotation
From the PCA loadings plots, metabolites of which the levels were affected by the extraction
temperature, were selected. Using the m/z of these metabolites, specific MS spectra were obtained
and various fragmentation patterns were observed. These spectra were used to identify the various
ions, and the identities of the ions were searched for and confirmed using online databases such as
Dictionary of Natural Products (DNP) [18] and KNApSAck [19]. For further structural confirmation,
MS data obtained with different collision energies (CE) were used to generate mass spectra containing
detailed fragmentation patterns of the biological markers.
4. Conclusions
The results of the current study successfully demonstrated PHWE as a feasible “greener”
extraction method of nutraceuticals from the medicinal plant V. fastigiata. The use of UHPLC-MS in
combination with cloud plots was employed for the first time to statistically optimize and verify the
pharmacological content from the PHWE extracts. Here, XCMS-based cloud plots were assessed in
conjunction with PCA score plot to evaluate the nature of metabolites of which the levels were affected
by variations in temperature for extraction. This use of the cloud plot allowed the visualization
of metabolites of varying polarities that were affected by temperature on different reverse-phase
chromatographic regions on the UHPLC-MS chromatograms.
This study is also the first scientific report that describes the diverse phytochemicals of
V. fastigiata, linking the presence of HCA-derivatives (e.g., CGAs, clovamide and deoxyclovamide) and
quercetin-derived flavonoids to its use as a medicinal plant. The presence of these phytochemicals
promotes the use of V. fastigiata for various pharmacological activities as discussed. To the best
of our knowledge this is the first report on the identification of clovamide and deoxyclovamide
in an Old World Vernonia species. Previously, Martucci et al. identified clovamide as a marker
for the chemotaxonomic classification of studied New World Vernonia species [1]. Such findings,
with the presence of clovamide in an Old World Vernonia species, may call for the study of other
chemotaxonomic markers linking Old World and New World Vernonia species.
Supplementary Materials: Supplementary Materials are available online. Figure S1: UHPLC ESI (neg) mass
chromatograms obtained from PHW extraction of V. fastigiata metabolites at: (A) 50 ◦C; (B) 100 ◦C; (C) 150 ◦C;
and (D) 200 ◦C. Figure S2: Extracted ion chromatograms of: (A) cis-clovamide; and (B) trans-clovamide. Figure
S3: Mass spectra showing the fragmentation pattern for both cis- and trans-clovamide. Figure S4: Mass spectra
showing the fragmentation pattern for deoxyclovamide.
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